[HTML][HTML] Interpol review of controlled substances 2016–2019
NS Jones, JH Comparin - Forensic science international: synergy, 2020 - Elsevier
This review paper covers the forensic-relevant literature in controlled substances from 2016
to 2019 as a part of the 19th Interpol International Forensic Science Managers Symposium …
to 2019 as a part of the 19th Interpol International Forensic Science Managers Symposium …
[HTML][HTML] The process–property–performance relationship of medicated nanoparticles prepared by modified coaxial electrospraying
W Huang, Y Hou, X Lu, Z Gong, Y Yang, XJ Lu, XL Liu… - Pharmaceutics, 2019 - mdpi.com
In pharmaceutical nanotechnology, the intentional manipulation of working processes to
fabricate nanoproducts with suitable properties for achieving the desired functional …
fabricate nanoproducts with suitable properties for achieving the desired functional …
[HTML][HTML] Synthesis, characterization and evaluation of deacetylated xanthan derivatives as new excipients in the formulation of chitosan-based polyelectrolytes for the …
M Boudoukhani, MM Yahoum, S Lefnaoui… - Saudi Pharmaceutical …, 2019 - Elsevier
This paper addressed the application of deacetylated xanthan (XGDS) and chitosan (CTS)
as a mixture blend forming hydrophilic matrices for Tramadol (TD) sustained release tablets …
as a mixture blend forming hydrophilic matrices for Tramadol (TD) sustained release tablets …
Controlled-release in-situ gel forming formulation of tramadol containing chitosan-based pro-nanogels
Chronic pain is one of the most prevalent health problems worldwide. Tramadol is a
synthetic semi-opioid analgesic, interacting with serotonergic, adrenergic and opioid …
synthetic semi-opioid analgesic, interacting with serotonergic, adrenergic and opioid …
Effect of tramadol hydrochloride on neural tube development in 48‐hr chick embryos: Argyrophilic nucleolar organizing region and genetic analysis study
Background Tramadol hydrochloride or tramadol is an opioid analgesic that acts on the
central nervous system. The pregnancy category of tramadol is determined as “C” according …
central nervous system. The pregnancy category of tramadol is determined as “C” according …
A novel tramadol–polycaprolactone implant could palliate heroin conditioned place preference and withdrawal in rats: behavioral and neurochemical study
SA Elshebiney, RA Elgohary… - Behavioural …, 2024 - journals.lww.com
Drug dependence is a chronic brain disease characterized by craving and recurrent
episodes of relapse. Tramadol HCl is a promising agent for withdrawal symptoms …
episodes of relapse. Tramadol HCl is a promising agent for withdrawal symptoms …
[HTML][HTML] Genotoxicity and repair capability of Mus musculus DNA following the oral exposure to Tramadol
T Ali, M Rafiq, MS Mubarik, K Zahoor, F Asad… - Saudi Journal of …, 2020 - Elsevier
Tramadol is an analgesic and psychoactive drug that acts primarily upon the central nervous
system where it alters brain function, resulting in temporary changes in perception, mood …
system where it alters brain function, resulting in temporary changes in perception, mood …
Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation
CA Cisneros-Covarrubias, CFA Gómez-Durán… - Journal of Drug Delivery …, 2022 - Elsevier
Thermally oxidized porous silicon particles have been widely studied as drug delivery
systems for sustained release. In this work, TOPSip with different particle and pore …
systems for sustained release. In this work, TOPSip with different particle and pore …
[PDF][PDF] Development of novel chitosan based ketorolac implant controlled release formulation for subcutaneous drug delivery.
SAU Rahman, S Siddique, MIM Abdul… - Biomedical …, 2018 - researchgate.net
This present experiment deals with a formulation of novel drug delivery system of chitosan
implants to modulate the release of ketorolac through the fabrication of subcutaneous …
implants to modulate the release of ketorolac through the fabrication of subcutaneous …
Central composite design optimization for a controlled valsartan release from polycaprolactone microspheres
O Sadoun‐Daikha… - Journal of Applied …, 2022 - Wiley Online Library
This investigation aimed to develop polycaprolactone (PCL) microspheres, which provide
better control of valsartan release. Central composite experimental design (2‐factor, 3‐level) …
better control of valsartan release. Central composite experimental design (2‐factor, 3‐level) …